Biotechnology

Viral Contamination Still a Challenge for CGT Industry

Ensuring raw materials are virus-free is still a major challenge for the cell an...

Antigen‑Stabilized Nanobody Probes Enable On‑Demand, Mu...

These “on‑demand” probes, known as VIS‑Fbs (visible-spectrum target-stabilizable...

Cosmo Pharma Eyes 2027 NDA for Baldness Candidate After...

Data from Cosmo’s Phase III program for clascoterone confirmed the drug’s long-t...

AACR 2026: Lung Cancer Immunotherapy Response Predicted...

Path-IO accurately stratified immunotherapy outcomes for patients with metastati...

Alzheimer’s Linked to Cancer Mutations in Brain Immune ...

The brain’s resident immune cells, microglia, amass mutations in specific cancer...

Navigating with Excellence: The Multi-Faceted Service L...

In this eBook, Marken experts share how these precision-driven services ensure t...

AACR 2026: A Video Update from San Diego

From the AACR Annual Meeting in San Diego, Julianna LeMieux and Damian Doherty r...

CRISPR Screens Map Human T‑Cell Genes That Promote or B...

Using genome‑wide CRISPR activation and knockout screens in primary human T cell...

CleanAssure Launched as an ISO Class 5 Controlled Clean...

Freudenberg Medical manufactures silicone and thermoplastic elastomer tubing for...

Lilly to Acquire Kelonia for Up to $7B, Expanding Cance...

Kelonia’s lead program KLN-1010 is a one-time intravenous gene therapy designed ...

Synthetic Biology and Tissue Engineering Grow Liver Tis...

Using engineered liver tissue as a proof-of-concept application, researchers int...

AACR 2026: Cancers of Unknown Primary Identified by DNA...

By analyzing CpG-based DNA methylation, researchers from Kindai University in Ja...

Colossal Biosciences said it cloned red wolves. Is it f...

If you want to capture something wolflike, it’s best to embark before dawn. So o...

Decoding Resistance to Targeted Therapy via New Cancer ...

Developing resistant models directly from patient tumors can take years due to s...

BIO kicks off ‘Fight of Our Lives,’ highlighting urgenc...

As biotech celebrates its 50th year, we are locked in “the fight of our lives” t...

StockWatch: Revolution’s Phase III Pancreatic Cancer Da...

In the trial’s overall (intent-to-treat) study population, daraxonrasib showed a...